Autor: |
Norio Okamoto, Yumiko Samejima, Shingo Nasu, Yoshimi Noda, Shoji Hashimoto, Ayako Tanaka, Hiromi Kawasumi, Hiroko Yoshida, Hidekazu Suzuki, Yoshitaka Tamura, Toshio Tanaka, Kunimitsu Kawahara, Tomohiro Kanai, Naoko Morishita, Tomonori Hirashima, Akane Matsushita |
Rok vydání: |
2019 |
Předmět: |
|
Zdroj: |
Anticancer Research. 39:6231-6240 |
ISSN: |
1791-7530 0250-7005 |
DOI: |
10.21873/anticanres.13832 |
Popis: |
BACKGROUND/AIM The present study aimed to prospectively examine the usefulness of interferon-gamma (IFN-γ) release (IGR) as a biomarker in non-small-cell lung cancer patients receiving immune checkpoint inhibitor treatment (ICI-Tx). PATIENTS AND METHODS IGR was measured using enzyme-linked immunosorbent assay at four time points: within 14 days before ICI-Tx (T1), and 8±3 (T2), 22±7 (T3), and 43±7 (T4) days after ICI-Tx. RESULTS Twenty-nine patients were divided into three groups based on IFN-γ levels in the IGR-positive control: Group-1 (n=8) with |
Databáze: |
OpenAIRE |
Externí odkaz: |
|